Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan MacKenzie

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Medicinal Chemistry|April 2, 2004
Orally bioavailable competitive CCR5 antagonistsGebhard Thoma, François Nuninger, Marc Schaefer, et al.
Nature Communications|August 23, 2024
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapyZaid Taha, Mathieu Joseph François Crupi, Nouf Alluqmani, et al.
Cell|September 11, 2024
Safe and effective in vivo delivery of DNA and RNA using proteolipid vehiclesDouglas W Brown, Ping Wee, Prakash Bhandari, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Medicinal Chemistry|April 2, 2004
Orally bioavailable competitive CCR5 antagonistsGebhard Thoma, François Nuninger, Marc Schaefer, et al.
Nature Communications|August 23, 2024
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapyZaid Taha, Mathieu Joseph François Crupi, Nouf Alluqmani, et al.
Cell|September 11, 2024
Safe and effective in vivo delivery of DNA and RNA using proteolipid vehiclesDouglas W Brown, Ping Wee, Prakash Bhandari, et al.
Pageof 2